XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Statements of Cash Flows Statement - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Operating activities:          
Net loss attributable to the Company $ (3,494,000) $ (2,078,000) $ (195,560,000) $ (5,956,000)  
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest (3,602,000) (2,137,000) (199,075,000) (6,094,000)  
Reconciliation of net loss to net cash provided by (used in) operating activities:          
Depreciation expense 51,794,000 46,239,000 153,096,000 137,191,000  
Amortization of above and below Market Leases     (6,145,000) (4,525,000)  
Deferred fee income amortization     (3,710,000) (4,720,000)  
amortization of purchase option termination fee income (421,000) (1,283,000) (4,896,000) (6,900,000)  
Interest Income, Securities, Mortgage Backed 0 0 0 (95,000)  
Deferred Sales Inducement Cost, Amortization Expense     3,027,000 2,414,000  
Deferred loan cost amortization     5,177,000 4,752,000  
deferred interest income     (9,208,000) (10,206,000)  
Receipt of accrued interest income on real estate loans     10,179,000 2,318,000  
Gain (Loss) on Sale of Mortgage Loans     0 (751,000)  
Share-based Compensation (152,000) 0 5,463,000 0  
Gain (Loss) on Disposition of Assets     (3,789,000) 0  
Gain (Loss) From Unconsolidated Joint Ventures     120,000 0  
cash inflows purchase option terminations     4,800,000 1,330,000  
Gain (Loss) on Extinguishment of Debt 518,000 15,000 6,674,000 84,000  
noncash loan interest income     0 (637,000)  
Provision for Loan and Lease Losses     5,463,000 0  
cash inflows mortgage interest from consolidated VIE     0 13,398,000  
mortgage interes cash outflows consolidated VIE     0 (13,398,000)  
Changes in operating assets and liabilities:          
(Increase) in tenant accounts receivable     (15,769,000) (12,379,000)  
Payments for (Proceeds from) Tenant Allowance     (382,000) (570,000)  
Loans and Leases Receivable, Allowance 0 5,530,000 1,963,000 16,144,000  
(Increase) decrease in other assets     46,821,000 22,399,000  
Increase (Decrease) in Deferred Liabilities     22,851,000 0  
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability     15,013,000 0  
Increase in accounts payable and accrued expenses     (249,000) 730,000  
Net cash provided by (used in) operating activities     29,998,000 124,436,000  
Investing activities:          
Investments in real estate loans     (42,193,000) (74,668,000)  
Proceeds from Principal Repayments on Loans and Leases Held-for-investment     71,146,000 0  
Notes receivable issued     15,012,000 2,169,000  
Deferred acquisition fee on real estate loans     (9,624,000) (30,434,000)  
Deferred real estate loan income     (793,000) (5,399,000)  
Acquisition of properties, net     (185,970,000) (442,415,000)  
proceeds from sale of interest in joint venture     19,221,000 0  
return of capital from joint venture     12,250,000 0  
Receipt of insurance proceeds for capital improvements     0 746,000  
Proceeds from Sale of Productive Assets     787,000 0  
Additions to real estate assets - improvements     (39,158,000) (34,251,000)  
Payments to Acquire Investments     (50,000) 0  
Increase (Decrease) in Earnest Money Deposits Outstanding     (1,227,000) (952,000)  
AcquisitionFeesRelatedPartyCosts     0 (674,000)  
Payments to Acquire Mortgage Backed Securities (MBS) categorized as Held-to-maturity     0 (18,656,000)  
cash paid investment in CMBS     0 (12,278,000)  
Proceeds from Sale of Mortgage Backed Securities (MBS) categorized as Available-for-sale     0 53,445,000  
mortgage principal received from consolidated VIE     0 5,024,000  
Increase (Decrease) in Accounts and Notes Receivable     4,546,000 26,222,000  
Proceeds from Sale of Loans Receivable       747,000  
Net cash (used in) investing activities     (155,171,000) (530,027,000)  
Financing activities:          
Proceeds from mortgage notes payable     377,749,000 329,905,000  
Extinguishment of Debt, Amount     (173,409,000) (106,728,000)  
Payments for mortgage loan costs     (10,911,000) (6,738,000)  
Payments of Debt Issuance Costs     (5,733,000) 0  
payments received from real estate loan participants     0 (5,223,000)  
Proceeds from non-revolving lines of credit     321,000,000 240,200,000  
Payments on revolving lines of credit     (288,000,000) (247,200,000)  
Repayments of Short-term Debt     (70,000,000) 0  
mortgage principal paid to consolidated VIE     0 (5,024,000)  
cash flows financing proceeds repurchase agreements     0 4,857,000  
cash flows financing repayments repurchase agreements     0 (4,857,000)  
Proceeds from sales of Units, net of offering costs     159,096,000 380,016,000  
Proceeds from Warrant Exercises     24,000 9,875,000  
Preferred Stock, Redemption Amount     (82,003,000) (7,995,000)  
Dividends declared and paid     (33,271,000) (33,617,000)  
Proceeds from Issuance of Common Stock     4,522,000 0  
Payments of Ordinary Dividends, Preferred Stock and Preference Stock     (104,428,000) (81,025,000)  
Payments for deferred offering costs, net of non cash items     (10,669,000) (3,386,000)  
Proceeds from Noncontrolling Interests     99,000 2,050,000  
Net Cash Provided by (Used in) Financing Activities     83,947,000 465,110,000  
Cash and Cash Equivalents, Period Increase (Decrease)     (41,226,000) 59,519,000  
Cash beginning of period     137,253,000 87,690,000 $ 87,690,000
Cash end of period 96,027,000 147,209,000 96,027,000 147,209,000 137,253,000
Supplemental cash flow information:          
Cash paid for interest     84,172,000 76,563,000  
Noncash Investing and Financing Items [Abstract]          
Accrued capital expenditures     6,067,000 3,952,000  
Deemed noncash dividend     499,000 358,000  
Dividends payable to non controlling interests     130,000 225,000  
Payments of Ordinary Dividends, Noncontrolling Interest     119,000 0  
Accrued and payable deferred offering costs     38,000 252,000  
receivable for deferred offering costs     2,473,000 210,000  
Writeoff of fully amortized deferred loan costs     2,828,000 1,850,000  
Assets 4,731,062,000   4,731,062,000   4,770,560,000
Liabilities 3,060,204,000   3,060,204,000   $ 2,836,444,000
Notes Reduction     20,865,000 0  
Reclass of offering costs from deferred asset to equity     4,338,000 7,508,000  
Loan Receivable Transferred To Equity     0 47,797,000  
Non-Cash Contribution of Property into an Unconsolidated Joint Venture     38,443,000 0  
Loans Assumed     0 41,550,000  
Share-based Compensation     6,461,000 719,000  
Noncash settlement of loans     40,000 384,000  
loan fees received     882,000 1,347,000  
mortgage debt refinanced     86,669,000 65,607,000  
Operating Lease Assumed     15,912,000 0  
Variable Interest Entity, Primary Beneficiary          
Noncash Investing and Financing Items [Abstract]          
Assets 0 270,669,000 0 270,669,000  
Liabilities 0 270,669,000 0 270,669,000  
Common Stock [Member]          
Noncash Investing and Financing Items [Abstract]          
Dividends payable     8,876,000 11,823,000  
Series A Preferred Stock [Member]          
Noncash Investing and Financing Items [Abstract]          
Dividends payable     9,954,000 9,534,000  
Series M Preferred Stock [Member]          
Noncash Investing and Financing Items [Abstract]          
Dividends payable     1,097,000 714,000  
Series A1/M1 Preferred Stock          
Financing activities:          
Proceeds from Issuance of Common Stock 4,614,000        
Noncash Investing and Financing Items [Abstract]          
Dividends payable     545,000 0  
Parent [Member]          
Operating activities:          
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest (3,494,000) $ (2,078,000) $ (195,560,000) $ (5,956,000)  
Parent [Member] | Series A1/M1 Preferred Stock          
Financing activities:          
Proceeds from Issuance of Common Stock $ 4,614,000